|
KR20200144562A
|
|
In vitro and xenograft anti-tumor of halogenated-xanthene for refractory pediatric solid tumors
|
|
MX2018004556A
|
|
Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound.
|
|
US2010076246A1
|
|
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
|
|
US2005276753A1
|
|
Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
|
|
US2005276752A1
|
|
Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
|
|
US2002161035A1
|
|
Medicaments for chemotherapeutic treatment of disease
|
|
US2001022970A1
|
|
Intracorporeal medicaments for photodynamic treatment of disease
|
|
US7384623B1
|
|
High energy phototherapeutic agents
|
